What is the scope of this report?

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry. Read More

Which segments covered in this report?

Market is segmented by Types, Applications, Technology, End-use Industries, and Regions. Read More

What are the key factors covered in this report?

The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions. Read More

Pulmonary Arterial Hypertension (PAH) Market in China 2023

Q: Does this report offer customization?

Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs. Read More

Report Code : 935378
Industry : Healthcare and Pharmaceuticals
Published On : May 2023
Pages : 34
Publisher : Gen Consulting Company
Format:

Pulmonary Arterial Hypertension (PAH) is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It occurs when the pulmonary arteries, which carry blood from the heart to the lungs to pick up oxygen, become narrowed and stiff, resulting in increased resistance to blood flow and higher blood pressure in the arteries. PAH can cause symptoms such as shortness of breath, fatigue, chest pain, dizziness, and fainting. It can also lead to complications such as heart failure, blood clots, and infections. The pulmonary arterial hypertension market in China is projected to rise by USD 913.9 million by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of 39.27 percent during the forecast period.

This industry report offers market estimates of the China market, followed by a detailed analysis of the region. The China market data on pulmonary arterial hypertension can be segmented by region: Central South China, East China, North China, Northeast China, Northwest China, Southwest China.

The report also includes the profiles of leading companies such as Actelion Pharmaceuticals Ltd., Bayer AG, Beijing Tide Pharmaceutical Co. Ltd., GlaxoSmithKline plc, United Therapeutics Corporation.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?
▹ Get a detailed picture of the China Pulmonary Arterial Hypertension Market
▹ Identify segments/areas to invest in over the forecast period in the China Pulmonary Arterial Hypertension Market
▹ Understand the competitive environment, the market's leading players
▹ The market estimate for ease of analysis across scenarios in Excel format.
▹ Strategy consulting and research support for three months.
▹ Print authentication provided for the single-user license.

Part 1. Summary
Part 2. Introduction
Study period
Geographical scope
Market segmentation
Part 3. Pulmonary arterial hypertension market overview
Part 4. Market breakdown by region
Central South China
East China
North China
Northeast China
Northwest China
Southwest China
Part 5. Key companies
Actelion Pharmaceuticals Ltd.
Bayer AG
Beijing Tide Pharmaceutical Co., Ltd.
GlaxoSmithKline plc
United Therapeutics Corporation
Part 6. Methodology

Pulmonary Health Monitoring Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)

Price : US$ 3500	Date : Nov 2024
Category : Healthcare and Pharmaceuticals	Pages : 185

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3195	Date : Aug 2024
Category : Medical Devices	Pages : 189

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3195	Date : Aug 2024
Category : Medical Devices	Pages : 193

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3195	Date : Aug 2024
Category : Medical Devices	Pages : 196

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034.

Price : US$ 3495	Date : Aug 2024
Category : Medical Devices	Pages : 207

Choose License Type

Happy To Assist You

We will be happy to help you find what you need. Please call us or write to us:

Email
sales@worldwidemarketreports.com
United States Of America

+1-415-871-0703
United Kingdom

+44-203-289-4040
Australia

+61-2-4786-0457
INDIA

+91-848-285-0837

Frequently Asked Questions

What does this report covers?

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.

Does this report estimates the current market size?

The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.

Does the report provides Market Size in terms of – Value (US$ Mn) and Volume (Thousands Units)?

The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).

What are the key segments offered in this report?

Market is segmented by:

Which market dynamics covered in this report?

The report share key insights on the following:

It helps the businesses in making investments decisions.

Does this report offer customization?

Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.